Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-01-29 @ 4:33 AM
Study NCT ID:
NCT00083720
Status:
COMPLETED
Last Update Posted:
2011-05-25
First Post:
2004-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy
Sponsor:
Organization: